SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010047.pdf 0001415889-23-010047.rtf 0001415889-23-010047.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010046.pdf 0001415889-23-010046.rtf 0001415889-23-010046.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010045.pdf 0001415889-23-010045.rtf 0001415889-23-010045.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010049.pdf 0001415889-23-010049.rtf 0001415889-23-010049.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010048.pdf 0001415889-23-010048.rtf 0001415889-23-010048.xls
8-K	Report of unscheduled material events or corporate event	Jun 15, 2023	View HTML 0001104659-23-071597.pdf 0001104659-23-071597.rtf 0001104659-23-071597.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC 13G/A	An amendment to the SC 13G filing	May 10, 2023	View HTML 0000902219-23-000024.pdf 0000902219-23-000024.rtf 0000902219-23-000024.xls
8-K	Report of unscheduled material events or corporate event	May 4, 2023	View HTML 0001171843-23-002887.pdf 0001171843-23-002887.rtf 0001171843-23-002887.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-Q	Quarterly report which provides a continuing view of a company's financial position	May 4, 2023	View HTML 0001104659-23-055992.pdf 0001104659-23-055992.rtf 0001104659-23-055992.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Apr 25, 2023	View HTML 0001104659-23-049299.pdf 0001104659-23-049299.rtf 0001104659-23-049299.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.